Search research articles
Contact Us
Filters
Showing results (51-60 of 105) with videos related to
Page
of 11
Sort By:
Therapeutic Drug Monitoring
|
December 3, 2024
Dose Optimization of Amikacin in the Emergency Department: A Population Pharmacokinetics Simulation Study
Nada Dia, Sabrina De Winter, Matthias Gijsen, et al.
Clinical Pharmacokinetics
|
September 20, 2024
Model-Informed Precision Dosing of Tacrolimus: A Systematic Review of Population Pharmacokinetic Models and a Benchmark Study of Software Tools
Yannick Hoffert, Nada Dia, Tim Vanuytsel, et al.
Inflammatory Bowel Diseases
|
August 3, 2019
A Population Pharmacokinetic and Exposure-Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis
Erwin Dreesen, Wannee Kantasiripitak, Iris Detrez, et al.
British Journal of Clinical Pharmacology
|
February 19, 2021
The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseases
Wannee Kantasiripitak, Bram Verstockt, Dahham Alsoud, et al.
Journal of Crohn'S & Colitis
|
January 20, 2023
A Model-Based Tool for Guiding Infliximab Induction Dosing to Maximize Long-term Deep Remission in Children with Inflammatory Bowel Diseases
Wannee Kantasiripitak, Sebastian G Wicha, Debby Thomas, et al.
The American Journal of Gastroenterology
|
August 3, 2016
A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease
Thomas Billiet, Erwin Dreesen, Isabelle Cleynen, et al.
Clinical and Experimental Dermatology
|
March 4, 2022
Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis
Rani Soenen, Zhigang Wang, Lynda Grine, et al.
The Journal of Pediatrics
|
September 5, 2021
Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination Therapy
Karen van Hoeve, Nasim Sadat Seyed Tabib, Erwin Dreesen, et al.
Therapeutic Drug Monitoring
|
February 9, 2021
A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short Communication
Omar Elkayal, Isabel Spriet, Anne Uyttebroeck, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 5, 2021
Bosentan Alters Endo- and Exogenous Bile Salt Disposition in Sandwich-Cultured Human Hepatocytes
Marlies Oorts, Pieter Van Brantegem, Neel Deferm, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 105) with videos related to
Sort By:
Page
of 11
Therapeutic Drug Monitoring
|
December 3, 2024
Dose Optimization of Amikacin in the Emergency Department: A Population Pharmacokinetics Simulation Study
Nada Dia, Sabrina De Winter, Matthias Gijsen, et al.
Clinical Pharmacokinetics
|
September 20, 2024
Model-Informed Precision Dosing of Tacrolimus: A Systematic Review of Population Pharmacokinetic Models and a Benchmark Study of Software Tools
Yannick Hoffert, Nada Dia, Tim Vanuytsel, et al.
Inflammatory Bowel Diseases
|
August 3, 2019
A Population Pharmacokinetic and Exposure-Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis
Erwin Dreesen, Wannee Kantasiripitak, Iris Detrez, et al.
British Journal of Clinical Pharmacology
|
February 19, 2021
The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseases
Wannee Kantasiripitak, Bram Verstockt, Dahham Alsoud, et al.
Journal of Crohn'S & Colitis
|
January 20, 2023
A Model-Based Tool for Guiding Infliximab Induction Dosing to Maximize Long-term Deep Remission in Children with Inflammatory Bowel Diseases
Wannee Kantasiripitak, Sebastian G Wicha, Debby Thomas, et al.
The American Journal of Gastroenterology
|
August 3, 2016
A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease
Thomas Billiet, Erwin Dreesen, Isabelle Cleynen, et al.
Clinical and Experimental Dermatology
|
March 4, 2022
Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis
Rani Soenen, Zhigang Wang, Lynda Grine, et al.
The Journal of Pediatrics
|
September 5, 2021
Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination Therapy
Karen van Hoeve, Nasim Sadat Seyed Tabib, Erwin Dreesen, et al.
Therapeutic Drug Monitoring
|
February 9, 2021
A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short Communication
Omar Elkayal, Isabel Spriet, Anne Uyttebroeck, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 5, 2021
Bosentan Alters Endo- and Exogenous Bile Salt Disposition in Sandwich-Cultured Human Hepatocytes
Marlies Oorts, Pieter Van Brantegem, Neel Deferm, et al.
Page
of 11